Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
42.02
+0.80 (1.94%)
At close: Dec 20, 2024, 4:00 PM
43.00
+0.98 (2.33%)
After-hours: Dec 20, 2024, 5:29 PM EST

Verona Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
3,4391,7092,13344440576
Upgrade
Market Cap Growth
67.71%-19.90%380.79%9.47%435.09%-40.38%
Upgrade
Enterprise Value
3,2251,4721,90728320527
Upgrade
Last Close Price
42.0219.8826.136.727.005.75
Upgrade
PS Ratio
415.56-4657.4011.09--
Upgrade
PB Ratio
26.356.859.263.002.191.77
Upgrade
P/TBV Ratio
17.996.879.283.012.201.80
Upgrade
EV/Sales Ratio
573.40-4164.237.09--
Upgrade
Debt / Equity Ratio
0.940.210.050.040.030.03
Upgrade
Asset Turnover
0.02-0.000.20--
Upgrade
Quick Ratio
12.4732.5312.464.9113.823.94
Upgrade
Current Ratio
13.0333.3312.775.0914.264.23
Upgrade
Return on Equity (ROE)
-78.03%-22.67%-36.30%-33.39%-57.25%-64.01%
Upgrade
Return on Assets (ROA)
-28.05%-14.64%-17.97%-18.45%-31.68%-34.72%
Upgrade
Return on Capital (ROIC)
-35.24%-15.34%-20.29%-20.92%-35.14%-42.11%
Upgrade
Earnings Yield
-4.47%-3.18%-3.22%-12.53%-16.07%-53.55%
Upgrade
FCF Yield
-3.02%-2.94%-2.81%-7.50%-11.14%-56.67%
Upgrade
Buyback Yield / Dilution
-3.55%-19.86%-11.81%-79.97%-149.64%-0.21%
Upgrade
Total Shareholder Return
-3.55%-19.86%-11.81%-79.97%-149.64%-0.21%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.